| scholarly article | Q13442814 |
| editorial | Q871232 |
| review article | Q7318358 |
| P50 | author | Megan Van Noord | Q57054862 |
| Eugene Cone | Q60058166 | ||
| P2093 | author name string | Jonathan C Routh | |
| Henry E Rice | |||
| Elizabeth T Tracy | |||
| Stewart S Dalton | |||
| P2860 | cites work | Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group | Q24657000 |
| Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration | Q28083988 | ||
| Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion | Q28131654 | ||
| End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System | Q31010441 | ||
| Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor | Q31826551 | ||
| Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group | Q33181845 | ||
| Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group | Q33182388 | ||
| Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group | Q33375430 | ||
| TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia | Q34338441 | ||
| Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group | Q34446746 | ||
| WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study | Q34667826 | ||
| Controversies and advances in the management of Wilms' tumour | Q34794743 | ||
| Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study | Q34949192 | ||
| Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group | Q35185392 | ||
| Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma. | Q35586613 | ||
| Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome. | Q35773597 | ||
| Prognostic markers in nephroblastoma (Wilms' tumor). | Q36142728 | ||
| B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma. | Q36272357 | ||
| Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. | Q36439488 | ||
| The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma | Q36623109 | ||
| Subsets of very low risk Wilms tumor show distinctive gene expression, histologic, and clinical features | Q37435558 | ||
| B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence | Q37461823 | ||
| Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma | Q37461830 | ||
| Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor | Q38410435 | ||
| Expression of the lipogenic enzyme fatty acid synthase (FAS) as a predictor of poor outcome in nephroblastoma: an interinstitutional study | Q38452956 | ||
| Wilms tumors: relationship of nuclear deoxyribonucleic acid ploidy to patient survival. | Q38491968 | ||
| Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group | Q38508700 | ||
| Gain of 1q is a marker of poor prognosis in Wilms' tumors | Q39349862 | ||
| B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor. | Q43784781 | ||
| Differential expression of the heat shock protein 70 in the histological compartments of nephroblastomas | Q43802065 | ||
| Expression and prognostic value of platelet-derived growth factor-AA and its receptor α in nephroblastoma | Q44007807 | ||
| HER2/neu expression: a predictor for differentiation and survival in children with Wilms tumor | Q44425783 | ||
| Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group | Q44573108 | ||
| Bilateral Wilms' tumor: long-term survival and some epidemiological features | Q44614766 | ||
| Loss of heterozygosity analysis at different chromosome regions in Wilms tumor confirms 1p allelic loss as a marker of worse prognosis: a study from the Italian Association of Pediatric Hematology and Oncology | Q45760446 | ||
| p53 Immunohistochemistry expression in Wilms tumor: a prognostic tool in the detection of tumor aggressiveness | Q46629881 | ||
| Microsatellite analysis of the DCC gene in nephroblastomas: pathologic correlations and prognostic implications | Q46781654 | ||
| Bilateral Wilms tumor | Q47593815 | ||
| Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric O | Q47670734 | ||
| High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor. | Q50754124 | ||
| The expression of IL-6 and STAT3 might predict progression and unfavorable prognosis in Wilms' tumor. | Q51001524 | ||
| Increased tissue factor expression and poor nephroblastoma prognosis. | Q51815120 | ||
| Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. | Q53318349 | ||
| Anaplasia in unilateral Wilms' tumor: a report from the National Wilms' Tumor Study Pathology Center. | Q53520274 | ||
| The expression of HSP70 and HSP90alpha in children with Wilms tumor. | Q54597224 | ||
| Decreased E-cadherin expression correlates with higher stage of Wilms' tumors. | Q54676905 | ||
| Astrocyte elevated gene-1 overexpression in histologically favorable Wilms tumor is related to poor prognosis. | Q54771946 | ||
| High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor | Q59282688 | ||
| Loss of Imprinting of Insulin-Like Growth Factor-II (IGF2) Gene in Distinguishing Specific Biologic Subtypes of Wilms Tumor | Q63433243 | ||
| MIB-1 (KI-67) Proliferation Index and Cyclin-Dependent Kinase Inhibitor p27Kip1 Protein Expression in Nephroblastoma | Q63966372 | ||
| Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children. | Q64981211 | ||
| A third Wilms' tumor locus on chromosome 16q | Q67848748 | ||
| Molecular genetics of Wilms tumor | Q70978673 | ||
| Genotype/phenotype correlations in Wilms' tumor | Q71580257 | ||
| Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome | Q72373963 | ||
| Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1 | Q72577728 | ||
| Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma | Q73269404 | ||
| 16q heterozygosity loss in Wilms' tumour in children and its clinical importance | Q73550945 | ||
| Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor) | Q74493276 | ||
| Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms tumor | Q77358795 | ||
| Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma | Q77380414 | ||
| Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor | Q83985886 | ||
| Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor | Q87206471 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 1530-1535 | |
| P577 | publication date | 2016-05-31 | |
| P1433 | published in | Journal of Urology | Q15709979 |
| P1476 | title | Biomarkers for Wilms Tumor: A Systematic Review | |
| P478 | volume | 196 |
| Q91972546 | Aberrant expression and mechanism of miR-130b-3p/phosphatase and tensin homolog in nephroblastoma in children |
| Q47104294 | Association between long interspersed nuclear element-1 methylation levels and relapse in Wilms tumors |
| Q92016796 | Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour |
| Q92703125 | Genes Controlled by DNA Methylation Are Involved in Wilms Tumor Progression |
| Q95643669 | HOXB2 and FOXC1 synergistically drive the progression of Wilms tumor |
| Q91817106 | Insights into the Chemical Biology of Childhood Embryonal Solid Tumors by NMR-Based Metabolomics |
| Q90041553 | Loss of Heterozygosity at Chromosome 16q Is a Negative Prognostic Factor in Korean Pediatric Patients with Favorable Histology Wilms Tumor: A Report of the Korean Pediatric Hematology Oncology Group (K-PHOG) |
| Q88912690 | MicroRNA‑92a‑3p inhibits the cell proliferation, migration and invasion of Wilms tumor by targeting NOTCH1 |
| Q92134502 | Multi-Omics Integration Reveals a Competitive Endogenous RNAs Network for the Identification of Progression Biomarkers and the Stratification of Patients Diagnosed With Nephroblastoma |
| Q33772198 | Recent advances in the management of Wilms' tumor. |
| Q99630135 | Two rare cases of acute myeloid leukemia with t(8;16)(p11.2;p13.3) and 1q duplication: case presentation and literature review |
Search more.